<DOC>
	<DOC>NCT02503189</DOC>
	<brief_summary>The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome</brief_summary>
	<brief_title>A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Sjogren's Syndrome</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Dry eye patients with Sjögren's syndrome Corneal and conjunctival damage Severe ophthalmic disorder Punctal plugs or surgery for occlusion of the lacrimal puncta</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Dry eye syndromes</keyword>
	<keyword>Corneal diseases</keyword>
	<keyword>Conjunctival diseases</keyword>
</DOC>